Electroporation-Mediated Delivery of CRISPR Technologies for Liver Disease Cell Therapy and Modeling
- 30 September 2026
- book chapter
- Published by Springer Nature
- p. 1-21
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research settingHuman Genetics, 2020
- Gap and Tight Junctions in Liver2020
- Liver Repopulation by Cell Transplantation and the Role of Stem Cells in Liver Biology2020
- Cryopreserved neonatal hepatocytes may be a source for transplantation: Evaluation of functionality toward clinical useLiver Transplantation, 2018
- Long-Term Toxicity of Immunosuppressive Therapy2015
- The History and Use of Human Hepatocytes for the Treatment of Liver Diseases: The First 100 PatientsCurrent Protocols in Toxicology, 2014
- Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 12014
- Mature Hepatocytes Exhibit Unexpected Plasticity by Direct Dedifferentiation Into Liver Progenitor Cells in CultureHepatology, 2011
- Overcoming the Nuclear Barrier: Cell Cycle Independent Nonviral Gene Transfer with Linear Polyethylenimine or ElectroporationMolecular Therapy, 2002
- Hepatocyte transplantation in acute liver failureLiver Transplantation, 2000